Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer
2016 · Breast Cancer Research and Treatment · 79 citations
https://doi.org/10.1007/s10549-016-3825-9
C
Charles L. Wiggins
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
28
Papers
477
Citations
9
h-index
9
i10-index
Charles L. Wiggins is an academic researcher from University of New Mexico. The author has contributed to research in topics: Cancer Risks and Factors & Breast Cancer Treatment Studies & Estrogen and related hormone effects. The author has an h-index of 9, co-authored 24 publications.
Papers by this author
worksReproductive Factors and Risk of Luminal, HER2-Overexpressing, and Triple-Negative Breast Cancer Among Multiethnic Women
2016 · Cancer Epidemiology Biomarkers & Prevention · 58 citations
https://doi.org/10.1158/1055-9965.epi-15-1104
Estrogen receptor quantitative measures and breast cancer survival
2017 · Breast Cancer Research and Treatment · 26 citations
https://doi.org/10.1007/s10549-017-4439-6
Alcohol, smoking, and risk of <scp>H</scp>er2‐overexpressing and triple‐negative breast cancer relative to estrogen receptor‐positive breast cancer
2018 · International Journal of Cancer · 23 citations
https://doi.org/10.1002/ijc.31575
Recent Use of Oral Contraceptives and Risk of Luminal B, Triple-Negative, and HER2-Overexpressing Breast Cancer
2019 · Hormones and Cancer · 14 citations
https://doi.org/10.1007/s12672-019-00362-5
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat